查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球眼科激光市场：到 2028 年的预测——按产品、应用、最终用户和地区分析
市场调查报告书
商品编码
1218882

全球眼科激光市场：到 2028 年的预测——按产品、应用、最终用户和地区分析

Ophthalmic Lasers Market Forecasts to 2028 - Global Analysis By Product, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2022 年全球眼科激光市场规模将达到 13.7507 亿美元，预计到 2028 年将达到 20.2914 亿美元，预测期内復合年增长率为 6.7%。眼科激光是能够精确治疗各种眼部问题且几乎没有感染风险的工具。许多激光手术可以在没有麻醉的情况下进行，而且疼痛很小。眼科激光由于其安全性、准确性和相对经济性的结合而成为眼科领域特别有用的仪器。激光控制台、脚踏板和激光传输系统是激光系统的三大要素。可以使用通过光纤电缆连接到控制台的各种传输设备将激光能量传输到患者的眼睛。

研究发现，女性在儿童时期患近视的可能性比男性高 24%，但成年后患近视的可能性低 12%。其原因不明，但可能是由于荷尔蒙的变化和男女生活方式的差异。

市场动态

促进者

眼科疾病的患病率

屈光不正、年龄相关性黄斑变性、白内障、糖尿病性视网膜病变和青光眼等眼科疾病的全球患病率上升是推动眼科激光市场增长的关键因素之一。此外，眼科微创手术和技术创新的趋势推动了眼科激光设备市场的需求。此外，保持适当眼睛健康的需求不断增加，这将推动全球眼科激光市场的增长。

抑製剂

替代疗法的可用性

视力矫正替代疗法的可用性预计将阻碍眼科医用激光市场。眼科学中的激光替代疗法包括使用晶状体进行视力矫正，使用诸如有晶状体眼人工晶状体植入物和屈光晶状体置换手术等技术。美国白内障和屈光手术学会 (ASCRS) 的统计数据证实，选择标准人工晶状体手术（白内障手术被认为是安全的）的患者可以完全恢復视力。因此，视力矫正替代疗法的可用性预计会阻碍眼科医用激光市场。

机会

眼科激光治疗眼病的效率

年龄相关性青光眼、白内障、近视和其他眼病影响着许多患者，尤其是老年人。药物治疗对某些眼病的疗效一般，这就是眼科激光等治疗眼病的医疗器械市场不断增长的原因。世界卫生组织估计，全世界有 1800 万人因白内障而双眼失明。此外，近视、极度近视、老花眼等屈光问题患者较多，市场机会广阔。

威胁

成本高

由于医务人员监管不力，发生了很多不幸事件，这削弱了用户的信任。例如，直视强光引起的事故可能导致不可逆的眼睛损伤以及部分或完全失明。如果激光束击中未受保护的眼睛，也会造成伤害。同样，有一份名单列出了那些经常不愿接受这种待遇的人，这些人共同代表了相当大一部分潜在客户并阻碍了市场增长。

COVID-19 的影响

COVID-19 的爆发对眼科激光市场产生了相反的影响。在大流行期间，主要的医疗保健治疗已被推迟，以减少冠状病毒传播的机会。在大流行期间，主要的健康治疗已被推迟，以减少冠状病毒传播的机会。然而，由于 COVID 后放鬆管制，预计眼保健会有所增加。这些障碍正在影响眼科激光市场的增长。

飞秒激光细分市场预计将在预测期内成为最大的细分市场

飞秒激光部分估计有良好的增长；飞秒激光因为其极短的脉衝持续时间和红外激光。由于脉衝持续时间短，飞秒激光器可以传送激光能量，对周围组织几乎没有附带伤害。飞秒激光的优势还在于它们可以照射角膜内部或下方的任何地方，并且可以部分穿过光学混浊介质，例如水肿角膜。支持市场增长。

白内障切除部分预计在预测期内表现出最高的复合年增长率

由于易于切割和晶状体开口的激光碎裂，预计白内障切除术在预测期内将呈现最快的复合年增长率。与手工操作相比，此过程可产生更可靠、可重复和精确的切口。即使是熟练的外科医生也无法製作出与激光相同精度的完美圆形开口。医生之所以能够这样做，是因为激光可以进行精确可靠的切口，从而带来更好、更可预测的视觉效果。因此，上述所有因素都在推动市场增长。

市场占有率最高的地区

由于研发部门的发展、医疗改革的加强以及眼科领域的科学发展，亚太地区预计在预测期内将占据最大的市场份额。亚太地区眼科激光市场的扩张主要是由于医疗保健基础设施的改善以及配备最先进设备的医院数量的增加。此外，眼科激光系统的技术进步和眼科诊断设备市场的扩大将进一步推动眼科激光製造商的市场增长。

复合年增长率最高的地区

欧洲在全球眼科激光器市场中占有很大份额，预计在预测期内将保持这一主导地位，因此欧洲将成为预测期内復合年增长率最高的地区。其背景是眼科疾病患者数量的增加、对患者安全设备的需求增加、配备熟练医务人员的最先进医疗设施的可用性以及研发活动的数量随着重要公司的出现，政府对医疗保健系统的投资有所增加，从而推动了市场的增长。

重大发展

2022年12月，Novartis宣布将向绝经前和绝经后激素受体阳性、人类表皮生长因子受体2阴性（HR+/HER2？）晚期转移性乳腺癌（MBC）患者，包括伴有内臟危象的患者率先宣布- Quiscari (R) (ribociclib) 联合内分泌治疗 (CT) 的 RIGHT 选择 II 期试验的结果。

2022 年 12 月，Novartis宣布 Pluvicto □（ INN ：橹（177Lu）vipivotide tetraxetan）是一种靶向前列腺特异性膜抗原（ PSMA ）的放射配体治疗药物，在其关键的第三阶段研究中达到了主要终点， PSMAfore 宣布。

2022 年 12 月，Johnson & Johnson Vision 宣布在新加坡推出用于近视管理的 ACUVUE(R) Ability(TM) 1 天软性治疗镜片，开始治疗时 7 岁的每日佩戴一次性镜片可能会减缓 12 岁以上儿童的近视进展岁。

2022年11月，Bosh Health宣布根据Bosh Health条款不受限制地使用Bausch + Lomb。因此，1261229 BC Ltd. 的所有子公司，包括 Bausch + Lomb 及其子公司，也已成为本公司的非限制性子公司，因此不再受 Bosch Health 债务文件项下契约的约束。

本报告内容

  • 区域和国家细分市场细分
  • 给新进入者的战略建议
  • 涵盖 2020、2021、2022、2025 和 2028 年的市场数据
  • 涵盖市场趋势（市场驱动因素、驱动因素、机遇、威胁、挑战、投资机会、建议）
  • 基于市场估计的关键业务领域的战略建议
  • 竞争格局映射关键共同趋势
  • 公司概况，包括详细战略、财务状况和近期发展
  • 映射最新技术进步的供应链趋势

免费定制服务

订阅此报告的客户将免费获得以下自定义选项之一。

  • 公司简介
    • 其他市场参与者的综合概况（最多 3 家公司）
    • 主要参与者的 SWOT 分析（最多 3 家公司）
  • 区域细分
    • 根据客户要求对主要国家的市场估计、预测和復合年增长率（注：基于可行性检查。）
  • 竞争标桿
    • 根据产品组合、地域分布和战略联盟对主要参与者进行基准测试

目录

第一章内容提要

第二章前言

  • 概述
  • 利益相关者
  • 调查范围
  • 调查方法
    • 数据挖掘
    • 数据分析
    • 数据验证
    • 研究方法
  • 研究来源
    • 主要研究来源
    • 二手研究资源
    • 假设

第三章市场趋势分析

  • 促进者
  • 抑製剂
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5 全球眼科激光市场，按产品

  • 飞秒激光
  • 二极管激光器
  • 准分子激光
  • 其他产品

6. 全球眼科激光市场，按应用

  • 白内障摘除
  • 青光眼
  • 糖尿病性视网膜病变
  • 屈光不正矫正
  • 其他应用

7. 全球眼科激光市场，按最终用户分类

  • 眼科
  • 医院
  • 其他最终用户

8.按地区分列的全球眼科激光市场

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 意大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 新西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中东和非洲
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 卡塔尔
    • 南非
    • 其他中东

第九章主要进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十章公司简介

  • Novartis AG
  • Bausch Health Companies Inc.
  • Topcon Corporation
  • Johnson & Johnson Surgical Vision Inc.
  • IRIDEX Corporation
  • Ziemer Opthalmic Systems AG
  • LIGHTMED
  • SCHWIND eye-tech-solutions
  • Lumenis
  • Lumibird Group
  • Carl Zeiss Meditec AG
  • NIDEK Co., Ltd.
  • Abbott Medical Optics Inc
  • Alcon Inc
Product Code: SMRC22418

According to Stratistics MRC, the Global Ophthalmic Lasers Market is accounted for $1375.07 million in 2022 and is expected to reach $2029.14 million by 2028 growing at a CAGR of 6.7% during the forecast period. Ophthalmic lasers are tools that enable precision therapy for a variety of eye issues with little danger of infection. Numerous laser operations can be done without anaesthesia and with little to no pain. Ophthalmic lasers are a particularly helpful instrument in the field of ophthalmology due to its combination of safety, accuracy, and relative affordability. The laser console, the foot pedal, and the laser delivery system are the three main elements of a laser system. The laser energy can be delivered to the patient's eye using a variety of delivery devices that are linked to the console by a fibre optic cable.

According to the study, women were 24% more likely than men to develop myopia as children, but they were 12% less likely to do so as adults. It's unclear why this is the case, but it could be because men and women endure different hormonal shifts or different lifestyles.

Market Dynamics:

Driver:

Prevalence of Ophthalmic Disorders

The rise in prevalence of ophthalmic disorders such as refractive errors, age-related macular degeneration, cataract, diabetic retinopathy and glaucoma, among others across the globe, is one of the major factors driving the growth of ophthalmic lasers market. Moreover, inclination towards minimally invasive procedures and innovations in ophthalmic will propel the demand in ophthalmic laser machines market. Further, growing need for maintaining proper eye health will drive growth in the global ophthalmic lasers market.

Restraint:

Availability of Alternative Therapies

The availability of alternative therapies for vision correction is expected to hinder the ophthalmic medical lasers market. The alternatives for lasers in ophthalmology include using a lens for correcting the vision using techniques such as Phakic Intraocular Lens Implants, and Refractive Lens Exchange Surgery. According to the statistics by the American Society of Cataract and Refractive Surgery (ASCRS), patients who choose to have a standard IOL procedure, which is considered safe for cataract surgery, experience fully restored vision. Therefore, the availability of alternative therapies to correct vision is expected to hamper the ophthalmic medical lasers market.

Opportunity:

Efficiency of ophthalmic lasers in the treatment of ocular diseases

Age-related glaucoma, cataract, myopia, and other eye illnesses affect a considerable patient base, particularly the older population. Because medications are only moderately effective in treating certain eye conditions, there is a growing market for medical devices, such as ophthalmic lasers, to treat eye conditions. The world health organization estimates that 18 million people worldwide are blind on both sides as a result of cataract. Additionally, a significant patient population experiences refractive problems like myopia, extreme myopia, and presbyopia which are providing wide range of opportunities to the market.

Threat:

High Cost

Numerous unfortunate circumstances caused by the poor supervision of medical professionals have occurred, undermining user confidence. For instance, accidents brought on by looking steadily into the light might irreversibly harm the eye and cause partial or complete blindness. Additionally, when a laser beam is projected into somebody's unprotected eyes, damage can result. Likewise, there is a list of persons who are frequently discouraged from receiving such therapies taken as a whole they represent a sizable portion of potential clients hindering the market growth.

COVID-19 Impact

The COVID-19 outbreak had a contradictory effect on the market for ophthalmic lasers. Significant healthcare treatments were postponed during the pandemic to decrease the likelihood of corona virus transmission. Major health treatments were postponed during the pandemic to reduce the chance of corona virus transmission. However, due to the easing of regulations after COVID, an increase in ophthalmic treatments is anticipated. Such hindrances are affecting the growth of the ophthalmic lasers market.

The femtosecond lasers segment is expected to be the largest during the forecast period

The femtosecond lasers segment is estimated to have a lucrative growth; due to their infrared laser with incredibly little pulse duration is the femtosecond laser. The femtosecond laser can deliver laser energy with little collateral harm to the surrounding tissue because of its brief pulse duration. The femtosecond laser is also exceptional in that it may be directed anywhere inside or below the cornea and can partially pass through optically cloudy media, like an edematous cornea which are boosting the market growth.

The cataract removal segment is expected to have the highest CAGR during the forecast period

The cataract removal segment is anticipated to witness the fastest CAGR growth during the forecast period, due to its ease on making incision and lens opening are made fragmented using a laser. This procedure produces a more dependable, reproducible, and exact incision than can be achieved by hand. Even a skilled surgeon cannot create a perfectly round aperture with the same level of precision as a laser. Doctors can do that because of the laser's accuracy and reliability in making incisions which leads to a better and more predictable vision outcome. Therefore, all the above factors are driving the market growth.

Region with highest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the development of the R&D sector, an increase in healthcare reforms, and scientific developments in the field of ophthalmology. Asia-Pacific ophthalmic lasers market, primarily as a result of improvements in the healthcare infrastructure, an increase in the number of hospitals with cutting-edge equipment. Furthermore, technological advancements in ophthalmic laser systems and expansion of ophthalmic diagnostic equipment market will further aid ophthalmic laser manufacturers to increase the growth of the market

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to a substantial share of the worldwide market for ophthalmic lasers, and it is anticipated that it will continue to hold this dominance during the forecast period. This is attributed to a rise in the number of ophthalmic disabilities, an increase in the demand for patient safety devices, the accessibility of cutting-edge healthcare facilities with skilled healthcare workers, an increase in the number of Research and development activities along with a notable presence of crucial players, and an increase in government investment in the healthcare system thereby propelling the market growth.

Key players in the market

Some of the key players profiled in the Ophthalmic Lasers Market include Novartis AG , Bausch Health Companies Inc, Topcon Corporation, Johnson & Johnson Surgical Vision Inc, IRIDEX Corporation, Ziemer Opthalmic Systems AG, LIGHTMED, SCHWIND eye-tech-solutions, Lumenis, Lumibird Group, Carl Zeiss Meditec AG, NIDEK Co., Ltd, Abbott Medical Optics Inc and Alcon Inc.

Key Developments:

In Dec 2022, Novartis announced results from the RIGHT Choice Phase II trial evaluating Kisqali® (ribociclib) plus endocrine therapy (ET) against combination chemotherapy (CT) in the first-line setting for pre- and perimenopausal patients with aggressive forms of hormone receptor-positive, human epidermal growth factor receptor-2 negative (HR+/HER2?) metastatic breast cancer (MBC), including patients with visceral crisis.

In Dec 2022, Novartis announced the pivotal Phase III PSMAfore study with PluvictoTM (INN: lutetium (177Lu) vipivotide tetraxetan), a prostate-specific membrane antigen (PSMA)-targeted radioligand therapy, met its primary endpoint.

In Dec 2022, Johnson & Johnson Vision Announces Availability of ACUVUE® Abiliti™ 1-Day Soft Therapeutic Lenses for Myopia Management in Singapore, the daily wear, single-use, disposable lens has the potential to slow the progression of myopia in children who are 7 to 12 years old at the start of treatment.

In Nov 2022, Bausch Health Announces the Unrestricting of Bausch + Lomb Under Bausch Health Debt Covenants. In connection therewith, all of the subsidiaries of 1261229 B.C. Ltd., including Bausch + Lomb and its subsidiaries, are also now unrestricted subsidiaries of the Company and, as a result, are no longer subject to the covenants under the Bausch Health debt documents.

Products Covered:

  • Femtosecond Lasers
  • Diode Lasers
  • Excimer Lasers
  • Other Products

Applications Covered:

  • Cataract Removal
  • Glaucoma
  • Diabetic Retinopathy
  • Refractive Error Corrections
  • Other Applications

End Users Covered:

  • Eye Clinics
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Ophthalmic Lasers Market, By Product

  • 5.1 Introduction
  • 5.2 Femtosecond Lasers
  • 5.3 Diode Lasers
  • 5.4 Excimer Lasers
  • 5.5 Other Products

6 Global Ophthalmic Lasers Market, By Application

  • 6.1 Introduction
  • 6.2 Cataract Removal
  • 6.3 Glaucoma
  • 6.4 Diabetic Retinopathy
  • 6.5 Refractive Error Corrections
  • 6.6 Other Applications

7 Global Ophthalmic Lasers Market, By End User

  • 7.1 Introduction
  • 7.2 Eye Clinics
  • 7.3 Hospitals
  • 7.4 Other End Users

8 Global Ophthalmic Lasers Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Novartis AG
  • 10.2 Bausch Health Companies Inc.
  • 10.3 Topcon Corporation
  • 10.4 Johnson & Johnson Surgical Vision Inc.
  • 10.5 IRIDEX Corporation
  • 10.6 Ziemer Opthalmic Systems AG
  • 10.7 LIGHTMED
  • 10.8 SCHWIND eye-tech-solutions
  • 10.9 Lumenis
  • 10.10 Lumibird Group
  • 10.11 Carl Zeiss Meditec AG
  • 10.12 NIDEK Co., Ltd.
  • 10.13 Abbott Medical Optics Inc
  • 10.14 Alcon Inc

List of Tables

  • 1 Global Ophthalmic Lasers Market Outlook, By Region (2020-2028) ($MN)
  • 2 Global Ophthalmic Lasers Market Outlook, By Product (2020-2028) ($MN)
  • 3 Global Ophthalmic Lasers Market Outlook, By Femtosecond Lasers (2020-2028) ($MN)
  • 4 Global Ophthalmic Lasers Market Outlook, By Diode Lasers (2020-2028) ($MN)
  • 5 Global Ophthalmic Lasers Market Outlook, By Excimer Lasers (2020-2028) ($MN)
  • 6 Global Ophthalmic Lasers Market Outlook, By Other Products (2020-2028) ($MN)
  • 7 Global Ophthalmic Lasers Market Outlook, By Application (2020-2028) ($MN)
  • 8 Global Ophthalmic Lasers Market Outlook, By Cataract Removal (2020-2028) ($MN)
  • 9 Global Ophthalmic Lasers Market Outlook, By Glaucoma (2020-2028) ($MN)
  • 10 Global Ophthalmic Lasers Market Outlook, By Diabetic Retinopathy (2020-2028) ($MN)
  • 11 Global Ophthalmic Lasers Market Outlook, By Refractive Error Corrections (2020-2028) ($MN)
  • 12 Global Ophthalmic Lasers Market Outlook, By Other Applications (2020-2028) ($MN)
  • 13 Global Ophthalmic Lasers Market Outlook, By End User (2020-2028) ($MN)
  • 14 Global Ophthalmic Lasers Market Outlook, By Eye Clinics (2020-2028) ($MN)
  • 15 Global Ophthalmic Lasers Market Outlook, By Hospitals (2020-2028) ($MN)
  • 16 Global Ophthalmic Lasers Market Outlook, By Other End Users (2020-2028) ($MN)
  • 17 North America Ophthalmic Lasers Market Outlook, By Country (2020-2028) ($MN)
  • 18 North America Ophthalmic Lasers Market Outlook, By Product (2020-2028) ($MN)
  • 19 North America Ophthalmic Lasers Market Outlook, By Femtosecond Lasers (2020-2028) ($MN)
  • 20 North America Ophthalmic Lasers Market Outlook, By Diode Lasers (2020-2028) ($MN)
  • 21 North America Ophthalmic Lasers Market Outlook, By Excimer Lasers (2020-2028) ($MN)
  • 22 North America Ophthalmic Lasers Market Outlook, By Other Products (2020-2028) ($MN)
  • 23 North America Ophthalmic Lasers Market Outlook, By Application (2020-2028) ($MN)
  • 24 North America Ophthalmic Lasers Market Outlook, By Cataract Removal (2020-2028) ($MN)
  • 25 North America Ophthalmic Lasers Market Outlook, By Glaucoma (2020-2028) ($MN)
  • 26 North America Ophthalmic Lasers Market Outlook, By Diabetic Retinopathy (2020-2028) ($MN)
  • 27 North America Ophthalmic Lasers Market Outlook, By Refractive Error Corrections (2020-2028) ($MN)
  • 28 North America Ophthalmic Lasers Market Outlook, By Other Applications (2020-2028) ($MN)
  • 29 North America Ophthalmic Lasers Market Outlook, By End User (2020-2028) ($MN)
  • 30 North America Ophthalmic Lasers Market Outlook, By Eye Clinics (2020-2028) ($MN)
  • 31 North America Ophthalmic Lasers Market Outlook, By Hospitals (2020-2028) ($MN)
  • 32 North America Ophthalmic Lasers Market Outlook, By Other End Users (2020-2028) ($MN)
  • 33 Europe Ophthalmic Lasers Market Outlook, By Country (2020-2028) ($MN)
  • 34 Europe Ophthalmic Lasers Market Outlook, By Product (2020-2028) ($MN)
  • 35 Europe Ophthalmic Lasers Market Outlook, By Femtosecond Lasers (2020-2028) ($MN)
  • 36 Europe Ophthalmic Lasers Market Outlook, By Diode Lasers (2020-2028) ($MN)
  • 37 Europe Ophthalmic Lasers Market Outlook, By Excimer Lasers (2020-2028) ($MN)
  • 38 Europe Ophthalmic Lasers Market Outlook, By Other Products (2020-2028) ($MN)
  • 39 Europe Ophthalmic Lasers Market Outlook, By Application (2020-2028) ($MN)
  • 40 Europe Ophthalmic Lasers Market Outlook, By Cataract Removal (2020-2028) ($MN)
  • 41 Europe Ophthalmic Lasers Market Outlook, By Glaucoma (2020-2028) ($MN)
  • 42 Europe Ophthalmic Lasers Market Outlook, By Diabetic Retinopathy (2020-2028) ($MN)
  • 43 Europe Ophthalmic Lasers Market Outlook, By Refractive Error Corrections (2020-2028) ($MN)
  • 44 Europe Ophthalmic Lasers Market Outlook, By Other Applications (2020-2028) ($MN)
  • 45 Europe Ophthalmic Lasers Market Outlook, By End User (2020-2028) ($MN)
  • 46 Europe Ophthalmic Lasers Market Outlook, By Eye Clinics (2020-2028) ($MN)
  • 47 Europe Ophthalmic Lasers Market Outlook, By Hospitals (2020-2028) ($MN)
  • 48 Europe Ophthalmic Lasers Market Outlook, By Other End Users (2020-2028) ($MN)
  • 49 Asia Pacific Ophthalmic Lasers Market Outlook, By Country (2020-2028) ($MN)
  • 50 Asia Pacific Ophthalmic Lasers Market Outlook, By Product (2020-2028) ($MN)
  • 51 Asia Pacific Ophthalmic Lasers Market Outlook, By Femtosecond Lasers (2020-2028) ($MN)
  • 52 Asia Pacific Ophthalmic Lasers Market Outlook, By Diode Lasers (2020-2028) ($MN)
  • 53 Asia Pacific Ophthalmic Lasers Market Outlook, By Excimer Lasers (2020-2028) ($MN)
  • 54 Asia Pacific Ophthalmic Lasers Market Outlook, By Other Products (2020-2028) ($MN)
  • 55 Asia Pacific Ophthalmic Lasers Market Outlook, By Application (2020-2028) ($MN)
  • 56 Asia Pacific Ophthalmic Lasers Market Outlook, By Cataract Removal (2020-2028) ($MN)
  • 57 Asia Pacific Ophthalmic Lasers Market Outlook, By Glaucoma (2020-2028) ($MN)
  • 58 Asia Pacific Ophthalmic Lasers Market Outlook, By Diabetic Retinopathy (2020-2028) ($MN)
  • 59 Asia Pacific Ophthalmic Lasers Market Outlook, By Refractive Error Corrections (2020-2028) ($MN)
  • 60 Asia Pacific Ophthalmic Lasers Market Outlook, By Other Applications (2020-2028) ($MN)
  • 61 Asia Pacific Ophthalmic Lasers Market Outlook, By End User (2020-2028) ($MN)
  • 62 Asia Pacific Ophthalmic Lasers Market Outlook, By Eye Clinics (2020-2028) ($MN)
  • 63 Asia Pacific Ophthalmic Lasers Market Outlook, By Hospitals (2020-2028) ($MN)
  • 64 Asia Pacific Ophthalmic Lasers Market Outlook, By Other End Users (2020-2028) ($MN)
  • 65 South America Ophthalmic Lasers Market Outlook, By Country (2020-2028) ($MN)
  • 66 South America Ophthalmic Lasers Market Outlook, By Product (2020-2028) ($MN)
  • 67 South America Ophthalmic Lasers Market Outlook, By Femtosecond Lasers (2020-2028) ($MN)
  • 68 South America Ophthalmic Lasers Market Outlook, By Diode Lasers (2020-2028) ($MN)
  • 69 South America Ophthalmic Lasers Market Outlook, By Excimer Lasers (2020-2028) ($MN)
  • 70 South America Ophthalmic Lasers Market Outlook, By Other Products (2020-2028) ($MN)
  • 71 South America Ophthalmic Lasers Market Outlook, By Application (2020-2028) ($MN)
  • 72 South America Ophthalmic Lasers Market Outlook, By Cataract Removal (2020-2028) ($MN)
  • 73 South America Ophthalmic Lasers Market Outlook, By Glaucoma (2020-2028) ($MN)
  • 74 South America Ophthalmic Lasers Market Outlook, By Diabetic Retinopathy (2020-2028) ($MN)
  • 75 South America Ophthalmic Lasers Market Outlook, By Refractive Error Corrections (2020-2028) ($MN)
  • 76 South America Ophthalmic Lasers Market Outlook, By Other Applications (2020-2028) ($MN)
  • 77 South America Ophthalmic Lasers Market Outlook, By End User (2020-2028) ($MN)
  • 78 South America Ophthalmic Lasers Market Outlook, By Eye Clinics (2020-2028) ($MN)
  • 79 South America Ophthalmic Lasers Market Outlook, By Hospitals (2020-2028) ($MN)
  • 80 South America Ophthalmic Lasers Market Outlook, By Other End Users (2020-2028) ($MN)
  • 81 Middle East & Africa Ophthalmic Lasers Market Outlook, By Country (2020-2028) ($MN)
  • 82 Middle East & Africa Ophthalmic Lasers Market Outlook, By Product (2020-2028) ($MN)
  • 83 Middle East & Africa Ophthalmic Lasers Market Outlook, By Femtosecond Lasers (2020-2028) ($MN)
  • 84 Middle East & Africa Ophthalmic Lasers Market Outlook, By Diode Lasers (2020-2028) ($MN)
  • 85 Middle East & Africa Ophthalmic Lasers Market Outlook, By Excimer Lasers (2020-2028) ($MN)
  • 86 Middle East & Africa Ophthalmic Lasers Market Outlook, By Other Products (2020-2028) ($MN)
  • 87 Middle East & Africa Ophthalmic Lasers Market Outlook, By Application (2020-2028) ($MN)
  • 88 Middle East & Africa Ophthalmic Lasers Market Outlook, By Cataract Removal (2020-2028) ($MN)
  • 89 Middle East & Africa Ophthalmic Lasers Market Outlook, By Glaucoma (2020-2028) ($MN)
  • 90 Middle East & Africa Ophthalmic Lasers Market Outlook, By Diabetic Retinopathy (2020-2028) ($MN)
  • 91 Middle East & Africa Ophthalmic Lasers Market Outlook, By Refractive Error Corrections (2020-2028) ($MN)
  • 92 Middle East & Africa Ophthalmic Lasers Market Outlook, By Other Applications (2020-2028) ($MN)
  • 93 Middle East & Africa Ophthalmic Lasers Market Outlook, By End User (2020-2028) ($MN)
  • 94 Middle East & Africa Ophthalmic Lasers Market Outlook, By Eye Clinics (2020-2028) ($MN)
  • 95 Middle East & Africa Ophthalmic Lasers Market Outlook, By Hospitals (2020-2028) ($MN)
  • 96 Middle East & Africa Ophthalmic Lasers Market Outlook, By Other End Users (2020-2028) ($MN)